Page last updated: 2024-10-17

aminocaproic acid and Agnogenic Myeloid Metaplasia

aminocaproic acid has been researched along with Agnogenic Myeloid Metaplasia in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ANDERSSON, L1
LINDSTEDT, E1

Other Studies

1 other study available for aminocaproic acid and Agnogenic Myeloid Metaplasia

ArticleYear
FIBRINOLYSIS AND BLEEDING FOLLOWING APPENDECTOMY.
    Acta chirurgica Scandinavica, 1963, Volume: 126

    Topics: Aminocaproates; Aminocaproic Acid; Appendectomy; Blood Coagulation Tests; Blood Transfusion; Dosage

1963